Navigation Links
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Date:5/24/2013

NEW YORK, May 24, 2013 /PRNewswire/ -- In accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today announced acceptance levels its original offer for Elan Corporation (NYSE: ELN).

Background

On 2 May 2013, Echo Pharma Acquisition Limited ("Royalty Pharma") made an offer for the entire of the issued and to be issued share capital of Elan Corporation, plc ("Elan") (the "Original Offer"). 

On 20 May 2013, Royalty Pharma announced the terms of a revision to the Original Offer (the "Increased Offer"). The Increased Offer was made on 23 May 2013 and is an all cash offer of US$12.50 per Elan Share (including each Elan Share represented by an Elan ADS). The full terms of, and conditions to, the Increased Offer and the procedure for acceptance are set out in the revised offer document despatched by Royalty Pharma on 23 May 2013 (the "Revised Offer Document"). 

A reference in this announcement to the "Offer" means the Original Offer (including where the context so requires, any subsequent revision, variation, extension or renewal of the Original Offer, including in connection with the Increased Offer). Capitalised terms used but not defined in this announcement shall have the meaning given to them in the Revised Offer Document.

Royalty Pharma is making this announcement in accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the US Exchange Act.

Level of Acceptances

As at 1:00 p.m. (Irish time) / 8:00 a.m. (New York City time) on 23 May 2013 (being the date the Original Offer was revised), Royalty Pharma had received valid acceptances of the Offer (which had not been withdrawn) from Elan Stockholders in respect of 67,814 Elan Shares (including Elan Shares represented by Elan ADSs). These acceptances represent, at th
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
2. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
5. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Pharma Announces Proposal To Acquire Elan
8. Royalty Rates Take Center Stage in Biopharma Dealmaking
9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
10. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
11. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ... ), today announced the publication of Phase III PROCHIEVE® ... Ultrasound in Obstetrics & Gynecology , the leading peer-reviewed ... & Gynecology. The published results indicate ...
... SAN DIEGO, April 6, 2011 ... a leading global medical technology company, today announced ... of pharmaceutical waste, helping hospitals reduce cost, improve ... (Photo:   http://photos.prnewswire.com/prnh/20110406/LA78173 ) (Logo:   ...
Cached Medicine Technology:Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 2Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 3Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 4Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 5Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 6Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 7Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 8CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 2CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 3
(Date:4/22/2014)... may throw tantrums like toddlers, but their total ... say, a gerbil or fox squirrel, according to ... and birds ranging from orangutans to zebra finches. ... Yale and more than two-dozen other research institutions ... evolution of self-control, defined in the study as ...
(Date:4/22/2014)... LOS ANGELES (April 22, 2014) Cedars-Sinai stroke intervention ... Neurological Disorders and Stroke, part of the National Institutes ... fund a multicenter Phase II clinical trial of an ... will be used in combination with recombinant tissue plasminogen ... to treat ischemic strokes shortly after onset. In laboratory ...
(Date:4/22/2014)... We,ve all waited in line and most of us ... we would like. , For Will Mather, assistant ... of Science,s Integrated Science Curriculum, studying lines, or queues, ... deal with bottlenecks that limit the recycling of proteins. ... an assistant professor, has received attention from the National ...
(Date:4/22/2014)... A new prediction tool can help doctors better identify ... after surgery and therefore prevent the often deadly condition, ... the May issue of Anesthesiology . , Affecting ... (ARDS) is a sudden failure of the lungs caused ... to pneumonia or blood infection. High-risk patients can develop ...
(Date:4/21/2014)... OAK BROOK, Ill. Imaging of the coronary arteries ... of arterial plaque and could have a dramatic impact ... high risk of heart attacks and other cardiovascular events, ... the journal Radiology . , Plaque that forms ... in some cases, rupture, leading to potentially fatal heart ...
Breaking Medicine News(10 mins):Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:Queuing theory helps physicist understand protein recycling 2Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 3
... could boost sensitivity, amount of information offered by the ... could some day be injected into the body to ... amount of information provided by the images, according to ... act as "smart tags" that identify specific cells, tissues, ...
... of Survivor Cafe Continues Longstanding ... Community Support By Binson,s, DETROIT, June 18 The fight ... Komen Detroit Race for,the Cure(R) with the participation of 344 participants from ... the Komen Race for the Cure Series has been a celebration,of life, ...
... research awards to states in 2007 created more than ... from those new jobs, and,spurred more than $50 billion ... for NIH Threatens New Health Research, U.S.,Medical Leadership, and ... Institutes,of Health has a legacy of great medical accomplishments, ...
... VW Bus For Fundraising Contest, HERNDON, Va., June ... their hands on legendary rock band The Who,s Magic,Bus ... 1965, signed by Roger,Daltrey and Pete Townshend and specially ... target logo. The competition, in aid of Daltrey,s,charity Teenage ...
... June 21, 2008, New Alternatives,for Children (NAC), a New ... disabilities and/or chronic illnesses, will,hold its 3rd Annual NAC ... 12:00 noon to 3:30 pm rain or shine., ... family members,are expected to participate in the 2008 NAC ...
... June 18 After 25 years, 26 chapters,and more ... the brink of a new era. And, beginning in ... alike can read the latest news,and cutting-edge technologies with ... available, in its entirety, online, offering readers,more opportunities to ...
Cached Medicine News:Health News:'Micromagnets' May One Day Enhance MRI Technology 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 3Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 4Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 2Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 3Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 2Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 3Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 3Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 2Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 3
... The Foundation® PS knee offers a femoral option ... cam action that engages at 60 degrees of ... motion and allow for 130 degrees of flexion. ... design with prominent lateral flare. The constrained tibial ...
... System is designed to provide the surgeon ... clinical indications. Based on the clinically successful ... P.F.C. SIGMA continues a history of innovation ... to address implant longevity by maximizing femoro-tibial ...
... Knee System's curved-on-curved articulation maintains full inter-changeability. ... for better patient fit. The Maxim ... knee's proven concepts with expanded options to ... Maxim is indicated for use in total ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
Medicine Products: